|
Conducting clinical trials that can determine the
Therapeutic areas of interest include infectious |
Anthrax
BioThrax® (Anthrax Vaccine Adsorbed)
BioThrax (Anthrax Vaccine Adsorbed) Vaccine in Pregnancy Registry
NuThrax (Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant) Vaccine Candidate
Non-Hodgkin's Lymphoma (NHL)
Chronic Lymphocytic Leukemia (CLL)
There are no active trials at this time.
Cutaneous T-Cell Lymphoma
Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin (Phase 2)
Peripheral T-Cell Lymphoma
HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma (Phase 2/3)
Non-Hodgkin's Lymphoma
There are no completed trials at this time.
Centers for Disease Control and Prevention/Emergency Preparedness and Response/Anthrax
Anthrax Vaccine Immunization Program
HHS/FDA/Vaccines, Blood & Biologics/Anthrax
U.S. Department of Labor/Occupational Health & Safety Administration/Anthrax
IDSA/Bacillus anthracis (Anthrax)
Centers for Disease Control and Prevention/Avian Influenza (Bird Flu)
World Health Organization/Avian influenza
National Cancer Institute/Chronic Lymphocytic Leukemia Treatment (PDQ®)
National Cancer Institute/Non-Hodgkin Lymphoma
National Cancer Institute/What You Need to Know About™ Non-Hodgkin Lymphoma (booklet)
American Cancer Society/Learn About Cancer/Non-Hodgkin Lymphoma
Leukemia & Lymphoma Society®/Peripheral T-Cell Lymphoma Facts
Investigators:
To join the Emergent investigator community, submit this FORM
..............................................................................................................................................................................
Contact Research Organizations:
To register your CRO with Emergent, submit this FORM
